IMC Chicago’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,069
Closed -$318K 6680
2026
Q1
$318K Buy
+3,069
New +$324K ﹤0.01% 4521
2019
Q4
Sell
-54,241
Closed -$3.07M 842
2019
Q3
$3.07M Buy
+54,241
New +$3.12M 0.01% 381

Other funds holding PJP

IMC Chicago's PJP Position: Q2 2026 in Review

IMC Chicago sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 3,069 shares — an estimated $318K sold.

IMC Chicago first reported a position in PJP in Q3 2019 and held it in 2 quarters. The position peaked at $3.07M in Q3 2019. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • IMC Chicago reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 3,069 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $318K.
  • IMC Chicago first reported a position in Invesco Pharmaceuticals ETF in Q3 2019 and held it in 2 quarters.
  • IMC Chicago's Invesco Pharmaceuticals ETF position peaked at $3.07M in Q3 2019.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.